24 HR aspirin 162.5 MG Extended Release Oral Capsule

RxCUI: 1665356
RxNorm name: 24 HR aspirin 162.5 MG Extended Release Oral Capsule
Display name: Aspirin XR (Oral Pill)
Full name: 24 HR aspirin 162.5 MG Extended Release Oral Capsule
Term type: SCD
Status: Active
Strength: 162.5 mg
Dose form: 24 HR XR Cap
Route: Oral Pill
Updated: 2026-10-20 20:50:52

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 102015
Active start: 102015
Multiple ingredient: NO
Branded: NO

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
aspirin	162.5 MG / 1 EACH	aspirin	aspirin

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Extended Release Oral Capsule	316943

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
aspirin	1191

Source Vocabulary Codes#

Code type, Values, Count table
Code type	Values	Count	Category
PRESCRIBABLE	Y	1	ATTRIBUTES
RXNAV_STR	24 HR aspirin 162.5 MG Extended Release Oral Capsule	1	NAMES
RxNorm Name	24 HR aspirin 162.5 MG Extended Release Oral Capsule	1	NAMES
RxNorm Synonym	2 linked values 24 HR ASA 162.5 MG Extended Release Oral Capsule aspirin 162.5 MG 24HR Extended Release Oral Capsule	2	NAMES
TTY	SCD	1	ATTRIBUTES
RxCUI	1665356	1	CODES
MMSL_CODE	CD30440	1	CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
4c2a1403-3862-1efd-0a91-444989222b37	aspirin 162.5 MG 24HR Extended Release Oral Capsule [PSN] · 24 HR aspirin 162.5 MG Extended Release Oral Capsule [SCD] · 24 HR ASA 162.5 MG Extended Release Oral Capsule [SY] · aspirin 162.5 MG 24HR Extended Release Oral Capsule [SY]	4	6	These highlights do not include all the information needed to use DURLAZA ™ safely and effectively. See full prescribing information for DURLAZA. DURLAZA (aspirin) Extended Release Capsules, for oral use Initial U.S. Approval:2015	20150925

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	A01AD	Other agents for local oral treatment	ATC1-4		aspirin
ATC	B01AC	Platelet aggregation inhibitors excl. heparin	ATC1-4		aspirin
ATC	N02BA	Salicylic acid and derivatives	ATC1-4		aspirin
FDASPL	N0000175722	Nonsteroidal Anti-inflammatory Drug	EPC	has_epc	aspirin
FDASPL	N0000175578	Platelet Aggregation Inhibitor	EPC	has_epc	aspirin
MEDRT	D001241	Aspirin	CHEM	has_ingredient	aspirin
MEDRT	D001172	Arthritis, Rheumatoid	DISEASE	may_treat	aspirin
MEDRT	D001778	Blood Coagulation Disorders	DISEASE	ci_with	aspirin
MEDRT	D001791	Blood Platelet Disorders	DISEASE	ci_with	aspirin
MEDRT	D002544	Cerebral Infarction	DISEASE	may_prevent	aspirin
MEDRT	D002644	Chickenpox	DISEASE	ci_with	aspirin
MEDRT	D002675	Child, Preschool	DISEASE	ci_with	aspirin
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	aspirin
MEDRT	D005334	Fever	DISEASE	may_treat	aspirin
MEDRT	D006073	Gout	DISEASE	may_treat	aspirin
MEDRT	D006396	Hematemesis	DISEASE	ci_with	aspirin
MEDRT	D006474	Hemorrhagic Disorders	DISEASE	ci_with	aspirin
MEDRT	D007223	Infant	DISEASE	ci_with	aspirin
MEDRT	D007249	Inflammation	DISEASE	may_treat	aspirin
MEDRT	D002546	Ischemic Attack, Transient	DISEASE	may_prevent	aspirin
MEDRT	D008551	Melena	DISEASE	ci_with	aspirin
MEDRT	D009203	Myocardial Infarction	DISEASE	may_prevent	aspirin
MEDRT	D009298	Nasal Polyps	DISEASE	ci_with	aspirin
MEDRT	D010003	Osteoarthritis	DISEASE	may_treat	aspirin
MEDRT	D010146	Pain	DISEASE	may_prevent	aspirin
MEDRT	D010146	Pain	DISEASE	may_treat	aspirin
MEDRT	D011225	Pre-Eclampsia	DISEASE	may_prevent	aspirin
MEDRT	D011263	Pregnancy Trimester, Third	DISEASE	ci_with	aspirin
MEDRT	D012213	Rheumatic Fever	DISEASE	may_treat	aspirin
MEDRT	N0000000160	Cyclooxygenase Inhibitors	MOA	has_moa	aspirin
MEDRT	N0000008831	Decreased Platelet Activating Factor Production	PE	has_pe	aspirin
MEDRT	N0000008832	Decreased Platelet Aggregation	PE	has_pe	aspirin
MEDRT	N0000008836	Decreased Prostaglandin Production	PE	has_pe	aspirin
MEDRT	N0000009006	Decreased Thromboxane Production	PE	has_pe	aspirin
MEDRT	N0000000026	Hepatic Metabolism	PK	has_pk	aspirin
MEDRT	N0000000042	Renal Excretion	PK	has_pk	aspirin

Group, Type, Concept table
Group	Type	Concept	Source
BN	BN	Durlaza	rxnav_allrelated
DF	DF	Extended Release Oral Capsule	rxnav_allrelated
DFG	DFG	Oral Product	rxnav_allrelated
DFG	DFG	Pill	rxnav_allrelated
IN	IN	aspirin	rxnav_allrelated
SBD	SBD	24 HR aspirin 162.5 MG Extended Release Oral Capsule [Durlaza]	rxnav_allrelated
SBDC	SBDC	aspirin 162.5 MG [Durlaza]	rxnav_allrelated
SBDF	SBDF	aspirin Extended Release Oral Capsule [Durlaza]	rxnav_allrelated
SBDG	SBDG	Durlaza Oral Product	rxnav_allrelated
SBDG	SBDG	Durlaza Pill	rxnav_allrelated
SCD	SCD	24 HR aspirin 162.5 MG Extended Release Oral Capsule	rxnav_allrelated
SCDC	SCDC	aspirin 162.5 MG	rxnav_allrelated
SCDF	SCDF	aspirin Extended Release Oral Capsule	rxnav_allrelated
SCDG	SCDG	aspirin Oral Product	rxnav_allrelated
SCDG	SCDG	aspirin Pill	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	AVAILABLE_STRENGTH	162.5 MG
ATTRIBUTES	GENERAL_CARDINALITY	SINGLE
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	QUANTITY	24 HR
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
CODES	VUID	4034864
NAMES	Prescribable Synonym	aspirin 162.5 MG 24HR Extended Release Oral Capsule
SOURCES	Source	National Drug Data File Plus Source Vocabulary